ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global IL-17 Monoclonal Antibody Injections Market Research Report 2024
Published Date: July 2024
|
Report Code: QYRE-Auto-38B17303
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global IL 17 Monoclonal Antibody Injections Market Research Report 2024
BUY CHAPTERS

Global IL-17 Monoclonal Antibody Injections Market Research Report 2024

Code: QYRE-Auto-38B17303
Report
July 2024
Pages:70
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
UCB
Eli Lilly and Co
Astrazeneca plc

IL-17 Monoclonal Antibody Injections Market

IL-17 monoclonal antibody injection refers to a monoclonal antibody drug developed by biotechnology that targets interleukin-17 (IL-17) and is used to treat certain autoimmune diseases such as psoriasis and rheumatoid arthritis. These drugs reduce inflammatory responses by inhibiting the action of IL-17.
The global IL-17 Monoclonal Antibody Injections market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for IL-17 Monoclonal Antibody Injections is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for IL-17 Monoclonal Antibody Injections is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of IL-17 Monoclonal Antibody Injections include Novartis, UCB, Eli Lilly and Co., AstraZeneca, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for IL-17 Monoclonal Antibody Injections, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IL-17 Monoclonal Antibody Injections.
The IL-17 Monoclonal Antibody Injections market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global IL-17 Monoclonal Antibody Injections market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IL-17 Monoclonal Antibody Injections manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of IL-17 Monoclonal Antibody Injections Market Report

Report Metric Details
Report Name IL-17 Monoclonal Antibody Injections Market
Segment by Type
  • Human Origin
  • Rat Origin
  • Other
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, UCB, Eli Lilly and Co., AstraZeneca
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of IL-17 Monoclonal Antibody Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of IL-17 Monoclonal Antibody Injections in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the IL-17 Monoclonal Antibody Injections Market report?

Ans: The main players in the IL-17 Monoclonal Antibody Injections Market are Novartis, UCB, Eli Lilly and Co., AstraZeneca

What are the Application segmentation covered in the IL-17 Monoclonal Antibody Injections Market report?

Ans: The Applications covered in the IL-17 Monoclonal Antibody Injections Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the IL-17 Monoclonal Antibody Injections Market report?

Ans: The Types covered in the IL-17 Monoclonal Antibody Injections Market report are Human Origin, Rat Origin, Other

1 IL-17 Monoclonal Antibody Injections Market Overview
1.1 Product Definition
1.2 IL-17 Monoclonal Antibody Injections by Type
1.2.1 Global IL-17 Monoclonal Antibody Injections Market Value Comparison by Type (2024-2030)
1.2.2 Human Origin
1.2.3 Rat Origin
1.2.4 Other
1.3 IL-17 Monoclonal Antibody Injections by Application
1.3.1 Global IL-17 Monoclonal Antibody Injections Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global IL-17 Monoclonal Antibody Injections Market Size Estimates and Forecasts
1.4.1 Global IL-17 Monoclonal Antibody Injections Revenue 2019-2030
1.4.2 Global IL-17 Monoclonal Antibody Injections Sales 2019-2030
1.4.3 Global IL-17 Monoclonal Antibody Injections Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 IL-17 Monoclonal Antibody Injections Market Competition by Manufacturers
2.1 Global IL-17 Monoclonal Antibody Injections Sales Market Share by Manufacturers (2019-2024)
2.2 Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Manufacturers (2019-2024)
2.3 Global IL-17 Monoclonal Antibody Injections Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of IL-17 Monoclonal Antibody Injections, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of IL-17 Monoclonal Antibody Injections, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of IL-17 Monoclonal Antibody Injections, Product Type & Application
2.7 Global Key Manufacturers of IL-17 Monoclonal Antibody Injections, Date of Enter into This Industry
2.8 Global IL-17 Monoclonal Antibody Injections Market Competitive Situation and Trends
2.8.1 Global IL-17 Monoclonal Antibody Injections Market Concentration Rate
2.8.2 The Global 5 and 10 Largest IL-17 Monoclonal Antibody Injections Players Market Share by Revenue
2.8.3 Global IL-17 Monoclonal Antibody Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global IL-17 Monoclonal Antibody Injections Market Scenario by Region
3.1 Global IL-17 Monoclonal Antibody Injections Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global IL-17 Monoclonal Antibody Injections Sales by Region: 2019-2030
3.2.1 Global IL-17 Monoclonal Antibody Injections Sales by Region: 2019-2024
3.2.2 Global IL-17 Monoclonal Antibody Injections Sales by Region: 2025-2030
3.3 Global IL-17 Monoclonal Antibody Injections Revenue by Region: 2019-2030
3.3.1 Global IL-17 Monoclonal Antibody Injections Revenue by Region: 2019-2024
3.3.2 Global IL-17 Monoclonal Antibody Injections Revenue by Region: 2025-2030
3.4 North America IL-17 Monoclonal Antibody Injections Market Facts & Figures by Country
3.4.1 North America IL-17 Monoclonal Antibody Injections Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America IL-17 Monoclonal Antibody Injections Sales by Country (2019-2030)
3.4.3 North America IL-17 Monoclonal Antibody Injections Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe IL-17 Monoclonal Antibody Injections Market Facts & Figures by Country
3.5.1 Europe IL-17 Monoclonal Antibody Injections Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe IL-17 Monoclonal Antibody Injections Sales by Country (2019-2030)
3.5.3 Europe IL-17 Monoclonal Antibody Injections Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific IL-17 Monoclonal Antibody Injections Market Facts & Figures by Region
3.6.1 Asia Pacific IL-17 Monoclonal Antibody Injections Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific IL-17 Monoclonal Antibody Injections Sales by Region (2019-2030)
3.6.3 Asia Pacific IL-17 Monoclonal Antibody Injections Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America IL-17 Monoclonal Antibody Injections Market Facts & Figures by Country
3.7.1 Latin America IL-17 Monoclonal Antibody Injections Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America IL-17 Monoclonal Antibody Injections Sales by Country (2019-2030)
3.7.3 Latin America IL-17 Monoclonal Antibody Injections Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa IL-17 Monoclonal Antibody Injections Market Facts & Figures by Country
3.8.1 Middle East and Africa IL-17 Monoclonal Antibody Injections Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa IL-17 Monoclonal Antibody Injections Sales by Country (2019-2030)
3.8.3 Middle East and Africa IL-17 Monoclonal Antibody Injections Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global IL-17 Monoclonal Antibody Injections Sales by Type (2019-2030)
4.1.1 Global IL-17 Monoclonal Antibody Injections Sales by Type (2019-2024)
4.1.2 Global IL-17 Monoclonal Antibody Injections Sales by Type (2025-2030)
4.1.3 Global IL-17 Monoclonal Antibody Injections Sales Market Share by Type (2019-2030)
4.2 Global IL-17 Monoclonal Antibody Injections Revenue by Type (2019-2030)
4.2.1 Global IL-17 Monoclonal Antibody Injections Revenue by Type (2019-2024)
4.2.2 Global IL-17 Monoclonal Antibody Injections Revenue by Type (2025-2030)
4.2.3 Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Type (2019-2030)
4.3 Global IL-17 Monoclonal Antibody Injections Price by Type (2019-2030)
5 Segment by Application
5.1 Global IL-17 Monoclonal Antibody Injections Sales by Application (2019-2030)
5.1.1 Global IL-17 Monoclonal Antibody Injections Sales by Application (2019-2024)
5.1.2 Global IL-17 Monoclonal Antibody Injections Sales by Application (2025-2030)
5.1.3 Global IL-17 Monoclonal Antibody Injections Sales Market Share by Application (2019-2030)
5.2 Global IL-17 Monoclonal Antibody Injections Revenue by Application (2019-2030)
5.2.1 Global IL-17 Monoclonal Antibody Injections Revenue by Application (2019-2024)
5.2.2 Global IL-17 Monoclonal Antibody Injections Revenue by Application (2025-2030)
5.2.3 Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Application (2019-2030)
5.3 Global IL-17 Monoclonal Antibody Injections Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis IL-17 Monoclonal Antibody Injections Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis IL-17 Monoclonal Antibody Injections Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 UCB
6.2.1 UCB Company Information
6.2.2 UCB Description and Business Overview
6.2.3 UCB IL-17 Monoclonal Antibody Injections Sales, Revenue and Gross Margin (2019-2024)
6.2.4 UCB IL-17 Monoclonal Antibody Injections Product Portfolio
6.2.5 UCB Recent Developments/Updates
6.3 Eli Lilly and Co.
6.3.1 Eli Lilly and Co. Company Information
6.3.2 Eli Lilly and Co. Description and Business Overview
6.3.3 Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Product Portfolio
6.3.5 Eli Lilly and Co. Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Company Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca IL-17 Monoclonal Antibody Injections Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AstraZeneca IL-17 Monoclonal Antibody Injections Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 IL-17 Monoclonal Antibody Injections Industry Chain Analysis
7.2 IL-17 Monoclonal Antibody Injections Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 IL-17 Monoclonal Antibody Injections Production Mode & Process
7.4 IL-17 Monoclonal Antibody Injections Sales and Marketing
7.4.1 IL-17 Monoclonal Antibody Injections Sales Channels
7.4.2 IL-17 Monoclonal Antibody Injections Distributors
7.5 IL-17 Monoclonal Antibody Injections Customers
8 IL-17 Monoclonal Antibody Injections Market Dynamics
8.1 IL-17 Monoclonal Antibody Injections Industry Trends
8.2 IL-17 Monoclonal Antibody Injections Market Drivers
8.3 IL-17 Monoclonal Antibody Injections Market Challenges
8.4 IL-17 Monoclonal Antibody Injections Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
UCB
Eli Lilly and Co
Astrazeneca plc
List of Tables
 Table 1. Global IL-17 Monoclonal Antibody Injections Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global IL-17 Monoclonal Antibody Injections Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global IL-17 Monoclonal Antibody Injections Market Competitive Situation by Manufacturers in 2023
 Table 4. Global IL-17 Monoclonal Antibody Injections Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global IL-17 Monoclonal Antibody Injections Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global IL-17 Monoclonal Antibody Injections Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market IL-17 Monoclonal Antibody Injections Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of IL-17 Monoclonal Antibody Injections, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of IL-17 Monoclonal Antibody Injections, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of IL-17 Monoclonal Antibody Injections, Product Type & Application
 Table 12. Global Key Manufacturers of IL-17 Monoclonal Antibody Injections, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global IL-17 Monoclonal Antibody Injections by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IL-17 Monoclonal Antibody Injections as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global IL-17 Monoclonal Antibody Injections Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global IL-17 Monoclonal Antibody Injections Sales by Region (2019-2024) & (K Units)
 Table 18. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Region (2019-2024)
 Table 19. Global IL-17 Monoclonal Antibody Injections Sales by Region (2025-2030) & (K Units)
 Table 20. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Region (2025-2030)
 Table 21. Global IL-17 Monoclonal Antibody Injections Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Region (2019-2024)
 Table 23. Global IL-17 Monoclonal Antibody Injections Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Region (2025-2030)
 Table 25. North America IL-17 Monoclonal Antibody Injections Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America IL-17 Monoclonal Antibody Injections Sales by Country (2019-2024) & (K Units)
 Table 27. North America IL-17 Monoclonal Antibody Injections Sales by Country (2025-2030) & (K Units)
 Table 28. North America IL-17 Monoclonal Antibody Injections Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America IL-17 Monoclonal Antibody Injections Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe IL-17 Monoclonal Antibody Injections Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe IL-17 Monoclonal Antibody Injections Sales by Country (2019-2024) & (K Units)
 Table 32. Europe IL-17 Monoclonal Antibody Injections Sales by Country (2025-2030) & (K Units)
 Table 33. Europe IL-17 Monoclonal Antibody Injections Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe IL-17 Monoclonal Antibody Injections Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific IL-17 Monoclonal Antibody Injections Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific IL-17 Monoclonal Antibody Injections Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific IL-17 Monoclonal Antibody Injections Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific IL-17 Monoclonal Antibody Injections Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific IL-17 Monoclonal Antibody Injections Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America IL-17 Monoclonal Antibody Injections Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America IL-17 Monoclonal Antibody Injections Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America IL-17 Monoclonal Antibody Injections Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America IL-17 Monoclonal Antibody Injections Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America IL-17 Monoclonal Antibody Injections Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa IL-17 Monoclonal Antibody Injections Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa IL-17 Monoclonal Antibody Injections Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa IL-17 Monoclonal Antibody Injections Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa IL-17 Monoclonal Antibody Injections Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa IL-17 Monoclonal Antibody Injections Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global IL-17 Monoclonal Antibody Injections Sales (K Units) by Type (2019-2024)
 Table 51. Global IL-17 Monoclonal Antibody Injections Sales (K Units) by Type (2025-2030)
 Table 52. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Type (2019-2024)
 Table 53. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Type (2025-2030)
 Table 54. Global IL-17 Monoclonal Antibody Injections Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global IL-17 Monoclonal Antibody Injections Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Type (2019-2024)
 Table 57. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Type (2025-2030)
 Table 58. Global IL-17 Monoclonal Antibody Injections Price (US$/Unit) by Type (2019-2024)
 Table 59. Global IL-17 Monoclonal Antibody Injections Price (US$/Unit) by Type (2025-2030)
 Table 60. Global IL-17 Monoclonal Antibody Injections Sales (K Units) by Application (2019-2024)
 Table 61. Global IL-17 Monoclonal Antibody Injections Sales (K Units) by Application (2025-2030)
 Table 62. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Application (2019-2024)
 Table 63. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Application (2025-2030)
 Table 64. Global IL-17 Monoclonal Antibody Injections Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global IL-17 Monoclonal Antibody Injections Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Application (2019-2024)
 Table 67. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Application (2025-2030)
 Table 68. Global IL-17 Monoclonal Antibody Injections Price (US$/Unit) by Application (2019-2024)
 Table 69. Global IL-17 Monoclonal Antibody Injections Price (US$/Unit) by Application (2025-2030)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis IL-17 Monoclonal Antibody Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Novartis IL-17 Monoclonal Antibody Injections Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. UCB Company Information
 Table 76. UCB Description and Business Overview
 Table 77. UCB IL-17 Monoclonal Antibody Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. UCB IL-17 Monoclonal Antibody Injections Product
 Table 79. UCB Recent Developments/Updates
 Table 80. Eli Lilly and Co. Company Information
 Table 81. Eli Lilly and Co. Description and Business Overview
 Table 82. Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Product
 Table 84. Eli Lilly and Co. Recent Developments/Updates
 Table 85. AstraZeneca Company Information
 Table 86. AstraZeneca Description and Business Overview
 Table 87. AstraZeneca IL-17 Monoclonal Antibody Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. AstraZeneca IL-17 Monoclonal Antibody Injections Product
 Table 89. AstraZeneca Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. IL-17 Monoclonal Antibody Injections Distributors List
 Table 93. IL-17 Monoclonal Antibody Injections Customers List
 Table 94. IL-17 Monoclonal Antibody Injections Market Trends
 Table 95. IL-17 Monoclonal Antibody Injections Market Drivers
 Table 96. IL-17 Monoclonal Antibody Injections Market Challenges
 Table 97. IL-17 Monoclonal Antibody Injections Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of IL-17 Monoclonal Antibody Injections
 Figure 2. Global IL-17 Monoclonal Antibody Injections Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global IL-17 Monoclonal Antibody Injections Market Share by Type: 2023 & 2030
 Figure 4. Human Origin Product Picture
 Figure 5. Rat Origin Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global IL-17 Monoclonal Antibody Injections Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global IL-17 Monoclonal Antibody Injections Market Share by Application: 2023 & 2030
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Other
 Figure 12. Global IL-17 Monoclonal Antibody Injections Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global IL-17 Monoclonal Antibody Injections Market Size (2019-2030) & (US$ Million)
 Figure 14. Global IL-17 Monoclonal Antibody Injections Sales (2019-2030) & (K Units)
 Figure 15. Global IL-17 Monoclonal Antibody Injections Average Price (US$/Unit) & (2019-2030)
 Figure 16. IL-17 Monoclonal Antibody Injections Report Years Considered
 Figure 17. IL-17 Monoclonal Antibody Injections Sales Share by Manufacturers in 2023
 Figure 18. Global IL-17 Monoclonal Antibody Injections Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest IL-17 Monoclonal Antibody Injections Players: Market Share by Revenue in IL-17 Monoclonal Antibody Injections in 2023
 Figure 20. IL-17 Monoclonal Antibody Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global IL-17 Monoclonal Antibody Injections Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America IL-17 Monoclonal Antibody Injections Sales Market Share by Country (2019-2030)
 Figure 23. North America IL-17 Monoclonal Antibody Injections Revenue Market Share by Country (2019-2030)
 Figure 24. United States IL-17 Monoclonal Antibody Injections Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada IL-17 Monoclonal Antibody Injections Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe IL-17 Monoclonal Antibody Injections Sales Market Share by Country (2019-2030)
 Figure 27. Europe IL-17 Monoclonal Antibody Injections Revenue Market Share by Country (2019-2030)
 Figure 28. Germany IL-17 Monoclonal Antibody Injections Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France IL-17 Monoclonal Antibody Injections Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. IL-17 Monoclonal Antibody Injections Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy IL-17 Monoclonal Antibody Injections Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia IL-17 Monoclonal Antibody Injections Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific IL-17 Monoclonal Antibody Injections Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific IL-17 Monoclonal Antibody Injections Revenue Market Share by Region (2019-2030)
 Figure 35. China IL-17 Monoclonal Antibody Injections Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan IL-17 Monoclonal Antibody Injections Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea IL-17 Monoclonal Antibody Injections Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India IL-17 Monoclonal Antibody Injections Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia IL-17 Monoclonal Antibody Injections Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan IL-17 Monoclonal Antibody Injections Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia IL-17 Monoclonal Antibody Injections Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America IL-17 Monoclonal Antibody Injections Sales Market Share by Country (2019-2030)
 Figure 43. Mexico IL-17 Monoclonal Antibody Injections Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil IL-17 Monoclonal Antibody Injections Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina IL-17 Monoclonal Antibody Injections Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia IL-17 Monoclonal Antibody Injections Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa IL-17 Monoclonal Antibody Injections Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa IL-17 Monoclonal Antibody Injections Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey IL-17 Monoclonal Antibody Injections Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia IL-17 Monoclonal Antibody Injections Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE IL-17 Monoclonal Antibody Injections Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of IL-17 Monoclonal Antibody Injections by Type (2019-2030)
 Figure 53. Global Revenue Market Share of IL-17 Monoclonal Antibody Injections by Type (2019-2030)
 Figure 54. Global IL-17 Monoclonal Antibody Injections Price (US$/Unit) by Type (2019-2030)
 Figure 55. Global Sales Market Share of IL-17 Monoclonal Antibody Injections by Application (2019-2030)
 Figure 56. Global Revenue Market Share of IL-17 Monoclonal Antibody Injections by Application (2019-2030)
 Figure 57. Global IL-17 Monoclonal Antibody Injections Price (US$/Unit) by Application (2019-2030)
 Figure 58. IL-17 Monoclonal Antibody Injections Value Chain
 Figure 59. IL-17 Monoclonal Antibody Injections Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global IL 17 Targeting Biological Drugs Market Research Report 2024
Global Interleukin 17 Inhibitors Market Research Report 2024
Global IL 17 Inhibitors for Psoriasis Market Research Report 2024
Global Arthritis Monoclonal Antibodies Market Research Report 2024
Global Secukinumab Market Research Report 2024
Global Monoclonal Antibodies for Plaque Psoriasis Market Research Report 2024
Global Infliximab Injection Market Research Report 2024
Global Anti TNF α Monoclonal Antibody Market Insights Forecast to 2030
Rituximab Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Monoclonal Antibodies for Alzheimer Disease Market Research Report 2024
Global Interleukin Inhibitors for Psoriasis Market Research Report 2024
Global Interleukin 17A IL 17A ELISA Kit Market Research Report 2024
Global Ustekinumab Biosimilars Market Research Report 2024
Global Rituximab Biosimilars Market Research Report 2025
Monoclonal Antibody Biologics and Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Rituximab Injection Market Research Report 2024
Global Therapeutic Monoclonal Antibodies Market Research Report 2024
Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024
Global Aβ Monoclonal Antibody Drug Market Research Report 2024
Global Emicizumab Injection Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions